Frequently Asked Questions

Exosomes are nanoscale extracellular vesicles — membrane-enclosed particles (30–150 nm) produced by cells. They carry proteins, lipids, and nucleic acids and function as intercellular communication vehicles. In skincare and aesthetic dermatology, they are being investigated for their potential as delivery vehicles and biologically active agents that may support skin quality, barrier function, and recovery contexts. They represent an emerging category within regenerative aesthetics.

An exosome skin booster is a professional-use product within the broader skin booster landscape — a category that includes HA, PDRN/polynucleotides, growth factors, and peptide-based actives. Exosome skin boosters are used in aesthetic workflows for hydration, texture, and skin quality support. Korean manufacturers have led the development of this sub-category, producing both single-active exosome products and complex multi-ingredient formulations.

Yes — meaningfully so. Plant-derived exosome-like nanovesicles (PDNVs) come from botanical sources and are studied for antioxidant/anti-inflammatory properties and skin-delivery potential. Technically, they are vesicle-like structures rather than true exosomes in the strict cellular biology sense. Human-derived exosomes come from human cell systems (often stem cell conditioned media) and have a different evidence base, primarily rooted in regenerative medicine and wound-healing literature. Both categories have significant open questions around standardization, efficacy, and regulatory status.

Growth factors (EGF, FGF, etc.) are individual proteins that bind to specific cell receptors to influence cellular behaviour. PDRN/polynucleotides are DNA fragments that act primarily via adenosine receptors to support tissue repair. Exosomes are multi-cargo vesicles that carry hundreds of bioactive molecules simultaneously — the hypothesis being that this complex cargo creates broader biological effects. Exosomes are newer and less evidence-established than growth factors or PDRN in aesthetic use.

EXO NAD+ is described by its Korean manufacturer as "Korea's first all-in-one skin rejuvenating solution." It is a plant-based exosome product positioned around skin renewal, barrier support, and vitality. It is used in aesthetic skincare workflows for skin quality and rejuvenation-focused protocols.

LXC Lacto Exo Colla is a fifth-generation exosomal skin enhancer that combines exosomes with lactic acid bacteria, plant stem cell cultures, PDRN, and peptides. It is positioned for wrinkle support, hydration, elasticity, density, and pigmentation concerns in professional aesthetic contexts — making it one of the more complex multi-ingredient Korean exosome products available.

EXOCODE Face uses Damask rose-derived exosomes and is positioned for radiance, vitality, and uneven skin tone support. It is a plant-based exosome skin booster used in aesthetic skincare workflows focused on radiance and brightening outcomes.

ASCE+ SRLV is a human-derived exosome product for skin rejuvenation, used in professional aesthetic settings for visible skin quality support — including hydration, widened pore appearance, dullness, and firmness contexts. It is one of the leading human-derived exosome skin products from Korea.

The rationale for combining microneedling with exosome application centres on microneedling's ability to create temporary microchannels in the skin surface, which may enhance topical penetration and delivery of applied actives. Exosome products are applied post-microneedling to support skin quality, recovery, and rejuvenation outcomes. This is a growing area of professional aesthetic interest — not settled clinical consensus. Evidence is still emerging.

Exotriple is the Korean exosome product with the most explicit microneedling workflow positioning on this site. Other products used in microneedling-related contexts include EXO NAD+, ASCE+ SRLV, Hanheal Exosome Rejuvenating, and Hairna Exosome Hair (for scalp microneedling). See the Microneedling Exosomes page for full context.

Growing investigational literature exists, but it is early-stage. Studies vary significantly in design, exosome source and characterization, dosing, and follow-up duration. Current reviews note the lack of standardization as a key limitation. Professional interest is ahead of the formal evidence base. No FDA-approved protocols exist for exosome use post-microneedling.

Hair and scalp-focused products on Exosome Korea include: LEUCO EXO HAIR (plant-based, scalp vitality), Hairna Exosome Hair (plant-based, microneedling-assisted scalp), EXO ROOT (plant-based, professional two-step scalp rejuvenation treatment), and ASCE+ HRLV (human-derived, premium scalp care for hair-loss concern contexts). EXO ROOT and ASCE+ HRLV are the primary anchor products of the scalp range.

EXO ROOT is a professional two-step scalp rejuvenation treatment from Korea, focused on scalp balance, follicular vitality support, and healthy hair growth support. It is the anchor product of the plant-based hair and scalp care range on Exosome Korea, positioned for professional scalp aesthetic and trichology-adjacent protocols.

No. Products on Exosome Korea are described for scalp vitality support, follicular environment, and professional hair-care workflows — not permanent hair regrowth. The evidence base does not support strong permanent regrowth claims for any exosome product, and no exosome products are currently FDA-approved for hair regrowth or any other indication.

No. The FDA has clearly stated that there are currently no FDA-approved exosome products for any use in humans. This applies to all exosome products — including those used in aesthetic, dermatology, and hair care contexts. All products described on Exosome Korea are discussed in professional and investigational frameworks only. This site does not make medical or therapeutic claims.

Korean aesthetic exosome products are typically manufactured and classified under Korean MFDS (Ministry of Food and Drug Safety) cosmetics or functional cosmetics frameworks. Long-term safety data specific to aesthetic exosome use is still accumulating. Practitioners should evaluate individual products based on available manufacturer safety documentation, regulatory classification in their practice market, and professional clinical judgment. This site does not provide safety assessments or endorsements.

Korean cosmetic and functional cosmetic classification under the MFDS framework differs significantly from FDA drug/device/biologic classification. Products classified as cosmetics in Korea may face drug or biologic regulatory requirements in the United States or EU if they make therapeutic claims or are delivered via injection. Practitioners and distributors importing Korean exosome products must assess destination-market regulatory requirements independently.

Yes — wholesale, clinic, and distributor inquiries are welcome via the Contact / Wholesale page. We work with clinics, aesthetic practitioners, and distribution networks to source Korean exosome products. Contact us to discuss product availability, pricing, volume tiers, and sourcing arrangements.

Minimum order quantities and pricing tiers depend on the specific product and order volume. Contact us via the Wholesale inquiry form with product interest and quantity requirements for a tailored response.

Start by identifying the primary use case — skin rejuvenation or hair/scalp care. Then consider whether a plant-based or human-derived formulation better fits your protocol context and market requirements. Within each category, further differentiation comes from co-formulation actives (PDRN, peptides, botanical extracts), application context (post-microneedling, standalone booster, scalp protocol), and specific concern focus (hydration, texture, pigmentation, follicular vitality). Our product pages and the Science & Evidence section provide detailed context for each product.